Methods
Methods and limitations
Each metric follows a published definition. Research describing a metric does not show that using Betawise improves health outcomes.
| Metric | Definition source | Limitations |
|---|---|---|
| Time in ranges | Battelino et al., International Consensus on Time in Range. Diabetes Care 2019;42:1593–1603 | Depends on how much of the period your CGM recorded. Reference targets describe populations, not an individual prescription. |
| Glucose management indicator (GMI) | Bergenstal et al. Diabetes Care 2018;41:2275–2280 | An estimate calculated from CGM averages. It is not a laboratory A1C result and can differ from one. |
| Glycemia Risk Index (GRI) | Klonoff et al. J Diabetes Sci Technol 2023;17:1215–1225 | A summary score of time spent low and high. It does not rule out urgent risk. |
| Coefficient of variation | Battelino et al. 2019 | Sensitive to gaps and short periods of data. |
| Patterns | Betawise rules applied to your readings, such as repeated lows in the same time window | Observations in past data, not a diagnosis. Each pattern shows its rule and the readings behind it. |
All results depend on the accuracy and completeness of your CGM data. Betawise does not fill in missing readings, and shows “Not enough usable data” when a period is too short to summarize.